A Brazilian study found that people with mild cognitive impairment who took lithium daily had decreased levels of phosphorylated tau (p-tau), a marker for Alzheimer's disease, and performed better on cognitive tests compared to those treated with placebo
factualpending
Speaker
AnnaEvidence Quote
“people with mild cognitive impairment who took lithium daily had decreased levels of a marker for Alzheimer's disease known as p and they also performed better on cognitive tests compared to those treated with Placebo”
Created: 8/10/2026, 9:28:36 PM
Your notes
Loading notes...